Sanofi Makes $10 Million Strategic Investment in Vicore Pharma Holding
October 19, 2024
October 19, 2024
BOSTON, Massachusetts, Oct. 19 -- Ropes and Gray, a law firm, issued the following news:
Ropes & Gray advised Sanofi in a $10 million strategic investment in Stockholm-based Vicore Pharma Holding AB.
Vicore plans to use the funding for its Phase 2b trial investigating the disease-modifying potential of buloxibutid for patients suffering from the lung disease idiopathic pulmonary fibrosis.
The transaction was announced on Sept. 30.
The Ropes . . .
Ropes & Gray advised Sanofi in a $10 million strategic investment in Stockholm-based Vicore Pharma Holding AB.
Vicore plans to use the funding for its Phase 2b trial investigating the disease-modifying potential of buloxibutid for patients suffering from the lung disease idiopathic pulmonary fibrosis.
The transaction was announced on Sept. 30.
The Ropes . . .